New regulatory framework emerges for digital medicine
This is a very detailed article on Digital Health regulation which is only just now reaching a reasonable level.&nbsp;The main issue is, what is the risk to the patient if this software fails? The FDA in the US and the EC have recently released extensive guidelines. The main areas of intervention are&nbsp;Human testing, Manufacturing,&nbsp;Software updates,&nbsp;Combination products and Hardware.
Medical Device Data Systems Final Rule, 76 FR 8637 FDA (2011).

US Department of Health and Human Services (HHS). FDA. Mobile Medical Applications: Guidance for Industry and FDA Staff (CDRH, 9 February 2015).

HHS. FDA. General Wellness: Policy for Low Risk Devices - Draft Guidance for Industry and FDA Staff. (CDRH, 20 January 2015).

HHS. FDA. Medical Device Data Systems, Medical Image Storage Devices, and Medical Image Communications Devices - Guidance for Industry and FDA Staff (CDRH, CBER, 9 February 2015).

US FDA. Examples of MMAs the FDA Regulates. HHS. 5 June 2015. http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ConnectedHealth/MobileMedicalApplications/ucm368743.htm

US FDA. Examples of Mobile Apps For Which the FDA Will Exercise Enforcement Discretion. HHS. 5 June 2015. http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ConnectedHealth/MobileMedicalApplications/ucm368744.htm

FDA. Federal Communications Commission. FDASIA Health IT Report: Proposed Strategy and Recommendations for a Risk-Based Framework (The Office of the National Coordinator for Health Information Technology, April 2014).

European Commission. DG Health and Consumers. Guidelines on the Qualification and Classification of Standalone Software Used in Healthcare within the Regulatory Framework of Medical Devices (January 2012).

Lakemedelsverket Medical Products Agency. Medical Information Systems: Guidance for Qualification and Classification of Standalone Software with a Medical Purpose (31 October 2012).

Elenko, E., Underwood, L. & Zohar, D. Nat. Biotechnol. 33, 456–461 (2015).

HHS. FDA. Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices (CDRH, CBER, 11 May 2015).

HHS. FDA. General Principles of Software Validation; Final Guidance for Industry and FDA Staff (CDRH, CBER, 11 January 2002).

HHS. FDA. Guidance for Industry and FDA Staff: Classification of Products as Drugs and Devices & Additional Product Classification Issues. Office of Combination Products in the Office of the Commissioner (CBER, Center for Drug Evaluation and Research, CDRH, June 2011).

FTC. FTC approves final settlement orders against marketers who claimed their mobile apps could cure acne (FTC, 25 October 2011).

FTC. FTC approves final order barring company from making unsubstantiated claims related to products' “Brain Training” capabilities (FTC, 9 April 2015).